* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 24
cents per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 30
cents per share.
* Revenue rose 7.7% to $1.65 million from a year ago;
analysts
expected $1.55 million.
* InspireMD Inc's reported EPS for the quarter was a loss
of 24
cents.
* The mean earnings estimate of analysts had risen by
about 56.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* InspireMD Inc shares had risen by 23.5% this quarter and
gained 260.7% so far this year.
* The company reported a quarterly loss of $5.08 million.
* Wall Street's median 12-month price target for InspireMD
Inc is
$4.13
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 8 at 01:33 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.30 -0.24 Beat
Mar. 31 2023 -0.68 -0.53 Beat
Dec. 31 2022 -0.84 -0.60 Beat
Sep. 30 2022 -0.73 -0.58 Beat